
Claritev Corp
NYSE:CTEV

Net Margin
Claritev Corp
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
US |
![]() |
Claritev Corp
NYSE:CTEV
|
652.2m USD |
-127%
|
|
US |
![]() |
Veeva Systems Inc
NYSE:VEEV
|
47.2B USD |
27%
|
|
US |
C
|
Cerner Corp
LSE:0R00
|
31.3B USD |
10%
|
|
AU |
![]() |
Pro Medicus Ltd
ASX:PME
|
33.5B AUD |
52%
|
|
US |
![]() |
Doximity Inc
NYSE:DOCS
|
11.5B USD |
39%
|
|
JP |
![]() |
M3 Inc
TSE:2413
|
1.3T JPY |
14%
|
|
SE |
![]() |
Sectra AB
STO:SECT B
|
71.4B SEK |
27%
|
|
US |
W
|
Waystar Holding Corp
NASDAQ:WAY
|
6.2B USD |
3%
|
|
US |
![]() |
Inspire Medical Systems Inc
NYSE:INSP
|
3.8B USD |
8%
|
|
CN |
![]() |
Winning Health Technology Group Co Ltd
SZSE:300253
|
23.4B CNY |
3%
|
|
IN |
I
|
Inventurus Knowledge Solutions Ltd
NSE:IKS
|
267.1B INR | N/A |
Claritev Corp
Glance View
Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 2,700 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Claritev Corp's most recent financial statements, the company has Net Margin of -127%.